UNSPSC 51293503: Pirandamine hydrochloride

This classification denotes an antidepressant agent with the molecular formula C17H23NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y4F9MIF6M1, chemically known as ay-23,713 but more generally known as pirandamine hydrochloride, which bears US NIH Compound Identifier 431429. Most nations, for tariff and trade purposes, schedule pirandamine hydrochloride under HS 29329985 and SITC 51569. As of Q4 2014, PIRANDAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Pirandamine hydrochloride bears US NLM identifiers UMLS ID C0088224 and NCI Concept Code C66411. SMILES: CC1(C2=C(CCO1)C3CCCCC3C2)CCN(C)C.CL.

UNSPSC 51293503 Pirandamine hydrochloride, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems rather than pirandamine hydrochloride, indicating a tagging mismatch between the code assignment and the work actually being procured. State and local governments do not appear to be actively sourcing pirandamine hydrochloride through public procurement channels at present.

Seminole County's June 2026 IFB, due July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic bid submission through the county's e-Procurement Portal, with vendors responsible for all shipping and delivery costs. Winners were required to carry workers' compensation, commercial general liability, and professional liability insurance, maintain E-Verify compliance, and comply with drug-free workplace certification. The contract structure provided an initial two-year term with a one-year renewal option and a three-month probationary period allowing termination at will. No explicit set-asides or disadvantaged-enterprise restrictions were stated, though the procurement noted potential FEMA funding with attendant federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. This opportunity does not represent typical pirandamine hydrochloride procurement and suggests that business development professionals should verify code assignments and focus on alternative sourcing channels or commodity classifications for pharmaceutical inputs in this family.